Clinical Trial Update: Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating brostallicin with cisplatin in metastatic triple-negative breast cancer has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Brostallicin (brostallicin)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-20